Real-world effectiveness of erenumab in Japanese patients with migraineKeisuke Suzuki, Koichi Hirata, Shiho Suzuki et al.|Heliyon|2024Cited by 12
The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraineKeisuke Suzuki, Koichi Hirata, Shiho Suzuki et al.|The Journal of Headache and Pain|2025Cited by 6
A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 monthsShiho Suzuki, Koichi Hirata, Keisuke Suzuki et al.|Neurological Research and Practice|2025Cited by 3
A Real‐World Study of <scp>CGRP</scp> Monoclonal Antibodies for Migraine: Long‐Term Effectiveness and Treatment AdherenceKeisuke Suzuki, K. Hirata, Shiho Suzuki et al.|European Journal of Neurology|2026Cited by 3
Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing scheduleShiho Suzuki, Koichi Hirata, Keisuke Suzuki et al.|Journal of the Neurological Sciences|2023Cited by 2